Phibro Animal Health (PAHC) Cash from Investing Activities (2013 - 2026)

Phibro Animal Health's Cash from Investing Activities history runs 14 years deep, the most recent figure standing at -$16.8 million for Q1 2026.

• In Q1 2026, Cash from Investing Activities rose 7.92% year-over-year to -$16.8 million; the TTM figure through Mar 2026 stood at -$62.0 million (up 78.66% YoY), while the FY2025 annual figure was -$288.7 million, down 499.01% from the prior year.
• Cash from Investing Activities was -$16.8 million for Q1 2026 at Phibro Animal Health, up from -$17.2 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $1.1 million in Q1 2024 to a low of -$260.5 million in Q4 2024.
• Historically, Cash from Investing Activities has averaged -$28.6 million across 5 years, with a median of -$15.4 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities surged 102.99% in 2024, then tumbled 1715.13% in 2025.
• A 5-year view of Cash from Investing Activities shows it stood at -$9.8 million in 2022, then plunged by 153.43% to -$24.9 million in 2023, then plunged by 947.72% to -$260.5 million in 2024, then jumped by 93.4% to -$17.2 million in 2025, then climbed by 2.2% to -$16.8 million in 2026.
• The last three Cash from Investing Activities figures came in at -$16.8 million (Q1 2026), -$17.2 million (Q4 2025), and -$21.0 million (Q3 2025), per Business Quant data.